Publications by authors named "Lucie Mrazova"
Article Synopsis
- Immunoglobulin substitution therapy is critical for patients with primary antibody deficiencies, with a new 20% subcutaneous immunoglobulin (SCIG) option using rapid-push application being evaluated in the Czech Hizentra Noninterventional Study (CHHINSTRAP).
- The study aims to assess patient satisfaction, tolerability, and efficacy after switching from previous intravenous (IVIG) or SCIG treatments to the new 20% SCIG.
- Preliminary findings show improved serum IgG levels and a decrease in infections and hospitalizations, indicating increased convenience and satisfaction among patients after the switch.
